Ozempic and Cancer Risk — What We Know - The Detection Trap

from Ozempic and Cancer Risk — What We Know · host Inception Point Ai

Join host Ben Synth as we examine the "detection trap" — when heightened surveillance creates the illusion of drug danger. We explore why Ozempic's thyroid cancer warnings may reflect statistical artifacts rather than real risk, analyzing large-scale studies showing no significant increase. Learn how detection bias distorts medical headlines and reshapes cancer screening debates.Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTVThis content was created in partnership and with the help of Artificial Intelligence AIThis episode includes AI-generated content.

Episode metadata supplied by the publisher feed · Published Apr 7, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

Ozempic and Cancer Risk — What We Know - The Detection Trap

0:00 26:25

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Ozempic and Cancer Risk — What We Know?

This episode is 26 minutes long.

When was this Ozempic and Cancer Risk — What We Know episode published?

This episode was published on April 7, 2026.

Is there a transcript available for this episode?

Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.

Can I download this Ozempic and Cancer Risk — What We Know episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!